TUCSON, Ariz.--(BUSINESS WIRE)--HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, today announced the appointment of Pete Clemens to Senior Vice President of Commercial Operations. Clemens’ primary responsibility will be leading global sales and commercialization efforts.
